Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

NCT01846455

Conditions: Blood-Borne Infections, Chronic Hepatitis C Infection With Hepatic Coma, Communicable Diseases, +13 more
Locations: Clinical Pharmacology of Miami, Inc. Hialeah, Florida, United States

Orlando Clinical Research Center Orlando, Florida, United States

American Research Corporation (ARC) San Antonio, Texas, United States

View Trial Details

Completed

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

NCT02057263

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

NCT02116179

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: University of Delaware Center for Drug and Alcohol Studies Coral Gables, Florida, United States

View Trial Details

Completed

Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation

NCT02125071

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +17 more
Locations: The Catholic University, Seoul St Mary Hospital Seoul, South Korea

View Trial Details

Completed

Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection

NCT02483156

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Egyptian Liver Hospital Sherbin, Dakahlia Governorate, Egypt

View Trial Details

Completed

An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection

NCT02278419

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Cairo, Egypt

Menoufiya, Egypt

View Trial Details

Completed

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

NCT02094443

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Novartis Investigative Site Bakersfield, California, United States

Novartis Investigative Site Lancaster, California, United States

Novartis Investigative Site San Diego, California, United States

Novartis Investigative Site San Diego, California, United States

View all 16 locations

View Trial Details

Completed

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00356564

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany

GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany

View all 42 locations

View Trial Details

Completed

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

NCT00320463

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Completed

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00335881

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 38 locations

View Trial Details